Panagiotis Neofytou

National and Kapodistrian University of Athens

Papers

Total Citations

H-Index

About

Dr. Panagiotis Neofytou is a leading urologic oncologist whose research centers on the surgical management of recurrent prostate cancer and the optimization of salvage therapies. His major contributions include a comprehensive, up-to-date review on the contemporary role of salvage radical prostatectomy for patients with biochemical recurrence after primary treatment—a critical area where evidence-based guidance remains scarce. This work, published in 2024, has already garnered 4 citations, reflecting its immediate relevance to clinicians navigating complex treatment decisions. Dr. Neofytou’s research systematically evaluates multimodal approaches, from whole-gland ablation to focal therapies, providing a roadmap for personalized salvage strategies. His scholarship bridges the gap between emerging technologies and established surgical techniques, offering clarity in a rapidly evolving field. By synthesizing outcomes across diverse treatment modalities—including radiotherapy, brachytherapy, and high-intensity focused ultrasound—he has helped define patient selection criteria and prognostic factors that improve oncologic control while minimizing morbidity. Dr. Neofytou’s work is essential reading for urologists and trainees seeking to understand the nuanced landscape of recurrent prostate cancer management, positioning him as a key voice in advancing salvage therapy paradigms.